{"result": "(\"entity\"<|>ABBOTT<|>ORGANIZATION<|>Abbott is a global healthcare company that develops and markets a wide range of nutritional products, including VITAL 1.5 and Glucerna 1.5.)\n##\n(\"entity\"<|>FRESENIUS KABI<|>ORGANIZATION<|>Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies, including nutritional products like Diben Drink.)\n##\n(\"entity\"<|>PERSAN FARMA<|>ORGANIZATION<|>Persan Farma is a pharmaceutical company that develops and markets nutritional products, including NutAvant Plus Diabética.)\n##\n(\"entity\"<|>NESTLÉ<|>ORGANIZATION<|>Nestlé is a multinational food and beverage company known for its wide range of products, including nutritional formulas like Resource Peptide and Resource Diabet Plus.)\n##\n(\"relationship\"<|>ABBOTT<|>VITAL 1.5<|>Abbott is the company that produces and markets VITAL 1.5<|>9)\n##\n(\"relationship\"<|>ABBOTT<|>GLUCERNA 1.5<|>Abbott is the company that produces and markets Glucerna 1.5<|>9)\n##\n(\"relationship\"<|>FRESENIUS KABI<|>DIBEN DRINK<|>Fresenius Kabi is the company that produces and markets Diben Drink<|>9)\n##\n(\"relationship\"<|>PERSAN FARMA<|>NUTAVANT PLUS DIABÉTICA<|>Persan Farma is the company that produces and markets NutAvant Plus Diabética<|>9)\n##\n(\"relationship\"<|>NESTLÉ<|>RESOURCE PEPTIDE<|>Nestlé is the company that produces and markets Resource Peptide<|>9)\n##\n(\"relationship\"<|>NESTLÉ<|>RESOURCE DIABET PLUS<|>Nestlé is the company that produces and markets Resource Diabet Plus<|>9)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: | Hidratos de carbono g/1000 kcal (%) | Lípidos g/1000 kcal (%) | Sodio Potasio mg/1000 kcal | Otros g Fibra/1000 kcal (sol/insol) Caract. espec. |\n|---------------------|---------|--------------|-------|---------------------------|-------------------------------------|------------------------|---------------------------|--------------------------------------------------|\n| Resource Peptide (Nestlé) | 1 | Botella 200 ml Vainilla | 280 | 40 (16%) Proteína Sérica hidrolizada 100% | 127 (51%) Maltodextrina, Sacarosa 23%, Almidón de maíz | 37 (33%) Aceites vegetales 30%, MCT 70% | 750 1150 | 0 |\n---\n# Anexo 4. Fórmulas enterales orales más empleadas en nuestro medio\n\n## Oligoméricas hiperproteicas hipercalóricas.\n\n| Producto® (Empresa) | kcal/ ml | Presentación | Osmol | Proteínas g/1000 kcal (%) | Hidratos de carbono g/1000 kcal (%) | Lípidos g/1000 kcal (%) | Sodio Potasio mg/1000 kcal | Otros g Fibra/1000 kcal (sol/insol) Caract. espec. |\n|---------------------|----------|--------------|-------|---------------------------|-------------------------------------|------------------------|---------------------------|--------------------------------------------------|\n| VITAL 1,5 (Abbott)   | 1,5      | Botellas 200 ml, Vainilla | 487 | 45 g (18%) Hidrolizado de lactoalbúmina | 122 (49%) Maltodextrina sacarosa | 36,6 (33%) 70% MCT | 1126 1333 | 0 |\n\n## Diabetes hiperproteicas hipercalóricas.\n\n| Producto® (Empresa) | kcal/ml | Presentación | Osmol | Proteínas g/1000 kcal (%) | Hidratos de carbono g/1000 kcal (%) | Lípidos g/1000 kcal (%) | Sodio Potasio mg/1000 kcal | Otros g Fibra/1000 kcal (sol/insol) Caract. espec. |\n|---------------------|---------|--------------|-------|---------------------------|-------------------------------------|------------------------|---------------------------|--------------------------------------------------|\n| Glucerna 1,5 (Abbott) | 1,5 | Botella 220 ml Vainilla, Botella 500 ml Vainilla | 671 | 50 (20%) Caseína, Soja | 85 (35%) DXM, Isomaltulosa, Glicerina, Fructosa, Sacromalt, | 50 (45%) | 900 1100 | 10 (85/15) Dietética, FOS Fibersol |\n| Diben Drink (Fresenius Kabi) | 1,5 | Botella 200 ml Vainilla, Frutos del bosque, Capuchino, Praliné, Multisabor | 350 (v, p), 360 (f), 390 (c) | 50 (20%) Leche | 87,3 (35%) DXM, Almidón modificado, Fructosa | 46,7 (42%) Colza, Girasol, Pescado; MCT; ω6/ω3 = 2,3 | 430 (v, p), 460 (f, c) 850 | 13,3 (96/4) Dextrina de tapioca |\n| NutAvant Plus Diabética (Persan Farma) | 1,2 | Botella 230 ml Capuchino, Chocolate, Plátano, Fresa, Vainilla | 315 | 55 (22%) Caseína, Leche | 100 (40%) Dextrina de maíz, | 38,8 (35%) Cánola, Leche, Soja; 15% MCT 50% Mono; ω6/ω3 = 2,27 | 90 1100 | 15 (100/0) Oligofructosa, Carragenato, Goma xantana |\n| Resource Diabet Plus (Nestlé) | 1,6 | Botella 200 ml, Vainilla, Fresa | 300 | 56 (23%), Caseína, Lactoproteína sérica | 98 (39%) Almidón, Isomaltulosa | 39 (35%) Aceites vegetales 100% | 1000 1060 | 15,6 (100/0) PHGG, Goma arábiga, FOS, Inulina |\n---\n# Anexo 4. Fórmulas enterales orales más empleadas en nuestro medio\n\n## Diabetes hiperproteicas normocalóricas.\n\n| Producto® (Empresa) | Kcal/ml | Presentación | Osmol | Proteínas g/1000 kcal (%) | Hidratos de carbono g/1000 kcal (%) | Lípidos g/1000 kcal (%) | Sodio Potasio mg/1000 kcal | g Fibra/1000 kcal (sol/insol) Caract. espec. | Otros |\n|---------------------|---------|--------------|-------|---------------------------|-------------------------------------|------------------------|---------------------------|----------------------------------------------|-------\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>RESOURCE PEPTIDE<|>ORGANIZATION<|>Resource Peptide is a product by Nestlé that provides nutritional support with specific macronutrient compositions.)\n##\n(\"entity\"<|>VITAL 1.5<|>ORGANIZATION<|>VITAL 1.5 is a product by Abbott designed for hypercaloric and hyperproteic dietary needs.)\n##\n(\"entity\"<|>GLUCERNA 1.5<|>ORGANIZATION<|>Glucerna 1.5 is a product by Abbott aimed at providing nutritional support for individuals with diabetes.)\n##\n(\"entity\"<|>DIBEN DRINK<|>ORGANIZATION<|>Diben Drink is a product by Fresenius Kabi that offers a variety of flavors for hypercaloric and hyperproteic diets.)\n##\n(\"entity\"<|>NUTAVANT PLUS DIABÉTICA<|>ORGANIZATION<|>NutAvant Plus Diabética is a product by Persan Farma designed for diabetic nutritional needs.)\n##\n(\"entity\"<|>RESOURCE DIABET PLUS<|>ORGANIZATION<|>Resource Diabet Plus is a product by Nestlé that provides nutritional support for diabetic patients.)\n##\n(\"relationship\"<|>RESOURCE PEPTIDE<|>NESTLÉ<|>Resource Peptide is a product developed and marketed by Nestlé<|>8)\n##\n(\"relationship\"<|>VITAL 1.5<|>ABBOTT<|>VITAL 1.5 is a product developed and marketed by Abbott<|>8)\n##\n(\"relationship\"<|>GLUCERNA 1.5<|>ABBOTT<|>Glucerna 1.5 is a product developed and marketed by Abbott<|>8)\n##\n(\"relationship\"<|>DIBEN DRINK<|>FRESENIUS KABI<|>Diben Drink is a product developed and marketed by Fresenius Kabi<|>8)\n##\n(\"relationship\"<|>NUTAVANT PLUS DIABÉTICA<|>PERSAN FARMA<|>NutAvant Plus Diabética is a product developed and marketed by Persan Farma<|>8)\n##\n(\"relationship\"<|>RESOURCE DIABET PLUS<|>NESTLÉ<|>Resource Diabet Plus is a product developed and marketed by Nestlé<|>8)\n<|COMPLETE|>"}]}